Gilead Sciences (board member)
E84182
Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
All labels observed (4)
| Label | Occurrences |
|---|---|
| Gilead Sciences | 19 |
| Gilead Sciences, Inc. | 2 |
| Gilead Sciences (board member) canonical | 1 |
| Gilead Sciences (headquarters) | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T705758 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Gilead Sciences (board member) Context triple: [Donald Rumsfeld, employer, Gilead Sciences (board member)]
-
A.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
B.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
-
C.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
-
D.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
E.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Gilead Sciences (board member) Target entity description: Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
-
A.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
B.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
-
C.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
-
D.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
E.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| developed |
bictegravir
ⓘ
emtricitabine ⓘ ledipasvir ⓘ remdesivir ⓘ sofosbuvir ⓘ tenofovir alafenamide ⓘ tenofovir disoproxil fumarate ⓘ velpatasvir ⓘ |
| focusesOn |
COVID-19 treatment
ⓘ
HIV treatment ⓘ antiviral drugs ⓘ hepatitis B treatment ⓘ hepatitis C treatment ⓘ |
| founded | 1987 ⓘ |
| foundedBy |
John C. Martin
ⓘ
Michael L. Riordan ⓘ Other early co-founders and investors ⓘ Paris Panayiotopoulos ⓘ |
| foundedIn |
California, United States
ⓘ
surface form:
California
|
| hasBoardOfDirectors | yes ⓘ |
| headquartersLocation |
Foster City, California
ⓘ
surface form:
Foster City, California, United States
|
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| isMajorCompanyIn | antiviral drug development ⓘ |
| knownFor |
HIV antiretroviral drugs
ⓘ
development of antiviral therapies ⓘ hepatitis C direct-acting antivirals ⓘ |
| listedOn | NASDAQ ⓘ |
| operatesIn | global market ⓘ |
| product |
Biktarvy
ⓘ
Descovy ⓘ Epclusa ⓘ Harvoni ⓘ Sovaldi ⓘ Truvada ⓘ Veklury ⓘ |
| researchFocus |
infectious diseases
ⓘ
inflammation ⓘ oncology ⓘ |
| revenueSource | prescription drugs ⓘ |
| specializesIn |
COVID-19 therapeutics
ⓘ
HIV/AIDS therapeutics ⓘ inflammatory diseases ⓘ oncology ⓘ viral hepatitis therapeutics ⓘ |
| tickerSymbol | GILD ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Gilead Sciences (board member) Description of subject: Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
Referenced by (23)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences (headquarters)
this entity surface form:
Gilead Sciences, Inc.
this entity surface form:
Gilead Sciences, Inc.
subject surface form:
Velpatasvir
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences